ACLA Elects 2021-2022 Board of Directors
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today announced the election of its new Board of Directors for 2021-2022.
William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, will take on a new leadership role as ACLA Board Chair, replacing Douglas M. VanOort of NeoGenomics Laboratories. Jerry Hussong, M.D., CEO of Sonic Healthcare USA was re-elected Vice Chair and John Kolozsvary, CEO of Joint Venture Hospital Laboratories, was re-elected Treasurer.
“Doug’s leadership, expertise and dedication to the industry have been an asset to the membership, and I am grateful for his extraordinary work leading the Board these last two years—a time of significant change and challenges for laboratories and the patients we serve,” said Julie Khani, president of ACLA.
“I look forward to continuing our work with the Board under Bill’s leadership to expand patient access to accurate and reliable tests and support the next generation of diagnostic breakthroughs for the patients who are counting on us,” said Khani. “Maintaining a vibrant laboratory industry is essential to our nation’s fight against chronic conditions and to ensure we’re prepared to defend against the next public health crisis.”
To view the full list of ACLA’s board members, click here.
The American Clinical Laboratory Association (ACLA) is the national trade association representing leading laboratories that deliver essential diagnostic health information to patients and providers. ACLA members are at the forefront of driving diagnostic innovation to meet the country’s evolving health care needs and provide vital clinical laboratory tests that identify and prevent infectious, acute and chronic disease. ACLA works to advance the next generation of health care delivery through policies that expand access to lifesaving testing services.